Literature DB >> 2680166

Measurement of lysozyme in human body fluids: comparison of various enzyme immunoassay techniques and their diagnostic application.

B Porstmann1, K Jung, H Schmechta, U Evers, M Pergande, T Porstmann, H J Kramm, H Krause.   

Abstract

Three variants of the immunoenzymometric assay of human lysozyme with HRP-labeled antibodies were compared. The highest sensitivity (with a detection limit of 0.2 micrograms lysozyme/L) was achieved by a one-step assay lasting 2 h. Between-batch precision for the techniques was 6-11%. Lysozyme reference values were determined in serum, cerebrospinal fluid and urine. In serum they are age-dependent and in urine sex-dependent when related to creatinine excretion. Serum lysozyme is increased in only 57% of the patients with active rheumatoid arthritis and is also unreliable for indicating remission. In Crohn's disease the serum lysozyme reflects activity better, but it does not exceed the diagnostic value of alpha-1-acidic glycoprotein (orosomucoid). The lysozyme quantification in cerebrospinal fluid is useful in distinguishing between viral or bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680166     DOI: 10.1016/s0009-9120(89)80031-1

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  17 in total

1.  Development of a microparticle-enhanced nephelometric immunoassay for quantitation of human lysozyme in pleural effusion and plasma.

Authors:  M Caballero; R Ruiz; M Márquez de Prado; M Seco; L Borque; J F Escanero
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Gradual pore formation in natural origin scaffolds throughout subcutaneous implantation.

Authors:  Ana M Martins; James D Kretlow; Ana R Costa-Pinto; Patrícia B Malafaya; Emanuel M Fernandes; Nuno M Neves; Catarina M Alves; Antonios G Mikos; F Kurtis Kasper; Rui L Reis
Journal:  J Biomed Mater Res A       Date:  2011-12-30       Impact factor: 4.396

3.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  In vitro degradation and drug release of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid) and chitosan.

Authors:  Claudia Lurtz; Karsten Voss; Veronika Hahn; Frieder Schauer; Juergen Wegmann; Erich K Odermatt; Klaus-Peter Schmitz; Katrin Sternberg
Journal:  J Mater Sci Mater Med       Date:  2012-12-30       Impact factor: 3.896

5.  Competition-mediated pyrene-switching aptasensor: probing lysozyme in human serum with a monomer-excimer fluorescence switch.

Authors:  Jin Huang; Zhi Zhu; Suwussa Bamrungsap; Guizhi Zhu; Mingxu You; Xiaoxiao He; Kemin Wang; Weihong Tan
Journal:  Anal Chem       Date:  2010-11-16       Impact factor: 6.986

6.  Zinc improves antibacterial, anti-inflammatory and cell motility activity of chitosan for wound healing applications.

Authors:  Nurshen Mutlu; Liliana Liverani; Fatih Kurtuldu; Dušan Galusek; Aldo R Boccaccini
Journal:  Int J Biol Macromol       Date:  2022-06-03       Impact factor: 8.025

7.  Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster.

Authors:  Janet R Kumita; Linda Helmfors; Jocy Williams; Leila M Luheshi; Linda Menzer; Mireille Dumoulin; David A Lomas; Damian C Crowther; Christopher M Dobson; Ann-Christin Brorsson
Journal:  FASEB J       Date:  2011-09-29       Impact factor: 5.191

8.  Electrically conductive chitosan/carbon scaffolds for cardiac tissue engineering.

Authors:  Ana M Martins; George Eng; Sofia G Caridade; João F Mano; Rui L Reis; Gordana Vunjak-Novakovic
Journal:  Biomacromolecules       Date:  2014-01-28       Impact factor: 6.988

9.  Graphene oxide-reinforced biodegradable genipin-cross-linked chitosan fluorescent biocomposite film and its cytocompatibility.

Authors:  Jianhua Li; Na Ren; Jichuan Qiu; Xiaoning Mou; Hong Liu
Journal:  Int J Nanomedicine       Date:  2013-09-02

10.  ProHNPs are specific markers of normal myelopoiesis.

Authors:  F Emmertsen; A Glenthøj; J Sønderskov; P Kampmann; H Sengeløv; N Borregaard
Journal:  Blood Cancer J       Date:  2014-03-21       Impact factor: 11.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.